Results 261 to 270 of about 78,245 (294)

Are take‐home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria

Addiction, 2016
Rebecca McDonald, John Strang
exaly  

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis

BMJ, The, 2013
Ziming Xuan, Al Ozonoff, Alexander Y Walley   +2 more
exaly  

Naloxon

1998
Markus Gastpar, Werner Heinz, Thomas Poehlke, Peter Raschke   +3 more
openaire   +1 more source

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Lancet Neurology, The, 2013
Birgit Högl, Alexander Oksche, Juliane Winkelmann   +2 more
exaly  

A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs

Journal of Addiction Medicine, 2014
Christine M Wilder, Erin L Winstanley
exaly  

Naloxone dosage for opioid reversal: current evidence and clinical implications

Therapeutic Advances in Drug Safety, 2018
Jeffrey Galinkin
exaly  

Naloxone

Inpharma Weekly, 1991
openaire   +1 more source

Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial

Lancet Neurology, The, 2015
Kallol Ray Chaudhuri, Pablo Martínez Martín, Olivier Rascol   +2 more
exaly  

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine

Drugs, 2019
John Strang, Rebecca McDonald, Gabrielle Campbell   +2 more
exaly  

Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic

International Journal of Drug Policy, 2017
Phillip O. Coffin, Alexander Y Walley
exaly